Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OTU domain-containing protein 7B (Human) | BDBM443362![]() (7-(1H-Indazol-4-yl)-2- oxo-1,2-dihydrospiro [pyrid...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443363![]() (7-(1-Methyl-1H-indazol- 4-yl)-2-oxo-1,2- dihydrosp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443251![]() (7'-(1-Methyl-1H-indazol-5-yl)- 2'-oxo-1',4'-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443372![]() (7-(5-Methyl-1H- indazol-4-yl)-2- oxo-1,4-dihydro- ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443364![]() (7-(1-(2-Hydroxyethyl)- 1H-indazol-4-yl)-2- oxo-1,2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443279![]() (7-(4-Fluorophenyl)-2-oxo- 1,2-dihydrospiro[pyrido ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443280![]() (7-(3-Fluorophenyl)-2-oxo- 1,2-dihydrospiro[pyrido ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443281![]() (2-Oxo-6-phenyl-1,2-dihydrospiro[pyrido[2,3-b][1,4]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443284![]() (US10654853, Example 57 | US11236092, Example 57) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443285![]() (7-(4-Cyanophenyl)-2- oxo-1,4-dihydro-2H- spiro[pyr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443286![]() (US10654853, Example 59 | US11236092, Example 59) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443287![]() (US10654853, Example 60 | US11236092, Example 60) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443291![]() ((S)-2-Oxo-7-phenyl-1,2-dihydrospiro[pyrido[2,3-b][...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443293![]() ((S)-2-Oxo-1,4- dihydro-2H- spiro[pyrido[2,3- b]pyr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443294![]() ((R)-2'-Oxo-6'- phenyl-1',4'- dihydro-2'H- spiro[py...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443295![]() ((S)-2-Oxo-7- phenyl- 1,4-dihydro-2H- spiro[pyrido[...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443296![]() ((S)-7-(3- Fluorophenyl)- 2-oxo-1,2- dihydrospiro [...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443297![]() ((S)-7-(4- Cyanophenyl)- 2-oxo-1,2- dihydrospiro [p...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443298![]() ((S)-7-(3- Cyanophenyl)- 2-oxo-1,2- dihydrospiro [p...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443299![]() ((S)-7-(4- Fluorophenyl)- 2-oxo-1,4- dihydro-2H- sp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443300![]() ((S)-7-(3- Fluorophenyl)- 2-oxo- 1,4-dihydro- 2H-sp...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443301![]() ((S)-7-(4- Fluorophenyl)- 2-oxo-1,2- dihydrospiro [...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443302![]() ((S)-7-(3-Cyanophenyl)-2-oxo-1,4-dihydro-2H-spiro[p...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443313![]() (2-Oxo-1,2,4,5-tetrahydrospiro[pyrido[2,3-b][1,4]di...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443314![]() (8-Methyl-7,10-dioxo-8-phenyl-2,6,9-triazaspiro[4.5...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443317![]() (7'-(3-(4-Methylpiperazine-1- carbonyl)phenyl)-2'-o...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443320![]() (6'-(4-(Benzyloxy)phenyl)-2'-oxo-1',4'- dihydro-2'H...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443321![]() (6'-(1-Methyl-1H-pyrazol-5-yl)-2'-oxo- 1',4'-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443322![]() (2'-Oxo-6'-(3- (trifluoromethoxy)phenyl)-1',4'- dih...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443324![]() (6'-(1-Methyl-1H-pyrazol-4-yl)-2'-oxo- 1',4'-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443325![]() (5-(1-Cyano-2'-oxo-1',4'-dihydro-2'H- spiro[pyrroli...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443327![]() (4-(1-Cyano-2'-oxo-1',4'-dihydro-2'H- spiro[pyrroli...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443328![]() (6'-(5-Isopropyl-2-methoxyphenyl)-2'- oxo-1',4'-dih...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443330![]() (6'-(6-Methoxypyridin-3-yl)-2'-oxo- 1',4'-dihydro-2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443331![]() (6'-(5-Fluoro-2-isopropoxyphenyl)-2'- oxo-1',4'-dih...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443332![]() (6'-(3-Methyl-1H-indazol-6-yl)-2'-oxo- 1',4'-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443334![]() (6'-(1-Methyl-1H-indazol-5-yl)-2'-oxo- 1',4'-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443335![]() (6'-(5-Methyl-1H-indazol-4-yl)-2'-oxo- 1',4'-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443336![]() (N-(3-(1-Cyano-2'-oxo-1',4'-dihydro- 2'H-spiro[pyrr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443337![]() (4-(1-Cyano-2'-oxo-1',4'-dihydro-2'H- spiro[pyrroli...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443338![]() (2'-Oxo-6'-(pyrimidin-5-yl)-1',4'- dihydro-2'H-spir...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443339![]() (N-(3-(1-Cyano-2'-oxo-1',4'-dihydro- 2'H-spiro[pyrr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443340![]() (N-(4-(1-Cyano-2'-oxo-1',4'-dihydro- 2'H-spiro[pyrr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443341![]() (6'-(3-(4-Methylpiperazine-1- carbonyl)phenyl)-2'-o...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443342![]() (6'-(1-Methyl-1H-pyrrol-2-yl)-2'-oxo- 1',4'-dihydro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443343![]() (6'-(4-(Morpholinosulfonyl)phenyl)-2'- oxo-1',4'-di...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443344![]() (6'-(3,5-Dimethyl-1H-pyrazol-4-yl)-2'- oxo-1',4'-di...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443345![]() (2'-Oxo-6'-(3-(piperidin-1-yl)phenyl)- 1',4'-dihydr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443346![]() (N-(2-(1-Cyano-2'-oxo-1',4'-dihydro- 2'H-spiro[pyrr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
OTU domain-containing protein 7B (Human) | BDBM443347![]() (6'-(4-(Morpholine-4-carbonyl)phenyl)- 2'-oxo-1',4'...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
MISSION THERAPEUTICS LIMITED US Patent | Assay Description Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po... | US Patent US10654853 (2020) BindingDB Entry DOI: 10.7270/Q21V5J02 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 147 total ) | Next | Last >> |